Blue Cell Therapeutics ApS — Credit Rating and Financial Key Figures
 CVR number: 39981610 
  Ole Maaløes Vej 3, 2200 København N 
 Income statement (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 | 
| Net sales | |||||
| Gross profit | -2 069.78 | - 843.70 | 852.13 | - 741.53 | -3 052.65 | 
| Employee benefit expenses | -12 007.23 | -8 474.46 | -11 642.95 | -14 195.72 | -12 785.68 | 
| Other operating expenses | - 873.82 | -5 845.13 | -3 735.73 | -2 986.32 | -1 539.57 | 
| Total depreciation | - 218.68 | - 273.58 | - 335.32 | - 163.37 | |
| EBIT | -14 950.83 | -15 381.97 | -14 800.13 | -18 258.89 | -17 541.26 | 
| Other financial expenses | -41.07 | -51.45 | -64.46 | -3.51 | -9.98 | 
| Pre-tax profit | -14 991.90 | -15 433.43 | -14 864.59 | -18 262.41 | -17 551.25 | 
| Income taxes | 965.00 | 1 192.02 | 2 294.63 | 2 974.03 | 2 361.40 | 
| Net earnings | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 | -15 189.85 | 
Assets (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 602.06 | 328.48 | 269.50 | 176.71 | |
| Tangible assets total | 602.06 | 328.48 | 269.50 | 176.71 | |
| Investments total | 56.24 | 103.80 | 82.60 | 122.60 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 138.84 | ||||
| Prepayments and accrued income | 6.46 | 118.65 | 36.77 | 99.84 | |
| Current other receivables | 18 793.54 | 576.14 | 1 477.86 | 3 164.73 | 3 809.65 | 
| Current deferred tax assets | 965.00 | 2 157.02 | 4 451.65 | 2 973.95 | 2 361.32 | 
| Short term receivables total | 19 758.54 | 2 739.62 | 6 187.00 | 6 175.45 | 6 270.81 | 
| Cash and bank deposits | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | 7 554.32 | 
| Cash and cash equivalents | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | 7 554.32 | 
| Balance sheet total (assets) | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 | 14 124.45 | 
Equity and liabilities (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 43.13 | 47.46 | 53.75 | 
| Share premium account | 29 962.00 | ||||
| Other reserves | 16 000.00 | ||||
| Retained earnings | -6 199.28 | 26 682.62 | 22 438.08 | 23 659.95 | 28 230.54 | 
| Profit of the financial year | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 | -15 189.85 | 
| Shareholders equity total | 25 775.82 | 12 481.21 | 9 911.25 | 8 419.03 | 13 094.43 | 
| Non-current liabilities total | |||||
| Current trade creditors | 963.40 | 885.33 | 327.89 | 668.23 | 573.82 | 
| Other non-interest bearing current liabilities | 514.88 | 638.19 | 385.51 | 1 071.92 | 456.20 | 
| Accruals and deferred income | 2 250.00 | ||||
| Current liabilities total | 3 728.27 | 1 523.53 | 713.41 | 1 740.15 | 1 030.02 | 
| Balance sheet total (liabilities) | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 | 14 124.45 | 
CreditReports API
 - Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
 - Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
 
 ... and more!
No registration needed.